115 related articles for article (PubMed ID: 37814477)
1. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity.
Matsushima-Nishiwaki R; Kamoi S; Kozawa O
Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine strengthens osteoblast activation by prostaglandin E
Tachi J; Tokuda H; Onuma T; Yamaguchi S; Kim W; Hioki T; Matsushima-Nishiwaki R; Tanabe K; Kozawa O; Iida H
Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106481. PubMed ID: 33002595
[TBL] [Abstract][Full Text] [Related]
3. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway.
Yamada N; Matsushima-Nishiwaki R; Kozawa O
Arch Biochem Biophys; 2020 Mar; 682():108296. PubMed ID: 32032576
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway.
Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Tachi J; Kozawa O
Arch Biochem Biophys; 2021 May; 703():108851. PubMed ID: 33771507
[TBL] [Abstract][Full Text] [Related]
5. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
6. Amplification by tramadol of PGD
Hioki T; Tokuda H; Tanabe K; Kim W; Tachi J; Yamaguchi S; Matsushima-Nishiwaki R; Kozawa O; Iida H
Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102323. PubMed ID: 34392133
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
Matsushima-Nishiwaki R; Toyoda H; Nagasawa T; Yasuda E; Chiba N; Okuda S; Maeda A; Kaneoka Y; Kumada T; Kozawa O
PLoS One; 2016; 11(4):e0151907. PubMed ID: 27046040
[TBL] [Abstract][Full Text] [Related]
8. Olive oil polyphenols suppress the TGF-α-induced migration of hepatocellular carcinoma cells.
Yamada N; Matsushima-Nishiwaki R; Masue A; Taguchi K; Kozawa O
Biomed Rep; 2019 Jul; 1(1):1-5. PubMed ID: 31258902
[TBL] [Abstract][Full Text] [Related]
9. Tramadol regulates the activation of human platelets via Rac but not Rho/Rho-kinase.
Iida H; Onuma T; Nakashima D; Mizutani D; Hori T; Ueda K; Hioki T; Kim W; Enomoto Y; Doi T; Matsushima-Nishiwaki R; Yamaguchi S; Tachi J; Tanabe K; Ogura S; Iwama T; Kozawa O; Tokuda H
PLoS One; 2023; 18(1):e0279011. PubMed ID: 36638092
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
Kuwahara J; Yamada T; Egashira N; Ueda M; Zukeyama N; Ushio S; Masuda S
Biol Pharm Bull; 2015; 38(9):1410-4. PubMed ID: 26328498
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine suppresses BMP-4-induced release of osteoprotegerin via inhibition of the SMAD signaling pathway in osteoblasts.
Tachi J; Onuma T; Yamaguchi S; Kim W; Hioki T; Matsushima-Nishiwaki R; Tanabe K; Tokuda H; Kozawa O; Iida H
Biochem Cell Biol; 2021 Oct; 99(5):578-586. PubMed ID: 33646885
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
13. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts.
Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094
[TBL] [Abstract][Full Text] [Related]
16. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 70 positively regulates transforming growth factor-α-induced hepatocellular carcinoma cell migration via the AKT signaling pathway.
Kobayashi K; Matsushima-Nishiwaki R; Yamada N; Migita S; Hioki T; Mizutani D; Kozawa O
Heliyon; 2020 Sep; 6(9):e05002. PubMed ID: 33005803
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
Cho JE; Park S; Cho SN; Lee H; Kim YS
BMB Rep; 2012 Oct; 45(10):583-8. PubMed ID: 23101513
[TBL] [Abstract][Full Text] [Related]
19. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
Park HJ; Kim BC; Kim SJ; Choi KS
Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
